Rchr
J-GLOBAL ID：201601004424490694   Update date: Mar. 06, 2024

HIDEKI TANI

タニ ヒデキ | HIDEKI TANI
Affiliation and department：
Toyama Institute of Health

About Toyama Institute of Health


Other affiliations (2)：
Research field  (1)： Virology
Research keywords  (4)： Antivirals ,  Viral vector ,  Emerging infectious disease ,  Virology
Research theme for competitive and other funds  (7)：
  • 2022 - 2025 ラクトフェリンと自然免疫受容体に着目したSARS-CoV-2感染制御機構の解明
  • 2022 - 2025 Molecular dissection of IgA antibody response by developing monoclonal IgA antibodies from nasal mucosa of mice
  • 2018 - 2021 Development of therapeutic and preventive vaccines for SFTS using recombinant viruses
  • 2015 - 2018 Study for entry receptor of emerging hemorrhagic fever virus and its application for antivirals
  • 2012 - 2015 Analyses of arenavirus cell entry mechanisms including novel entry factors
Show all
Papers (103)：
  • Tatsuhiko Ozawa, Yoshiki Ikeda, Liuan Chen, Rigel Suzuki, Atsushi Hoshino, Akira Noguchi, Shunsuke Kita, Yuki Anraku, Emiko Igarashi, Yumiko Saga, et al. Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1. Structure. 2024
  • Hikaru Fujii, Shuetsu Fukushi, Tomoki Yoshikawa, Noriyo Nagata, Satoshi Taniguchi, Masayuki Shimojima, Souichi Yamada, Hideki Tani, Akihiko Uda, Takahiro Maeki, et al. Pathological and virological findings of type I interferon receptor knockout mice upon experimental infection with Heartland virus. Virus research. 2023. 340. 199301-199301
  • Miyuki Kimura, Risa Matsuoka, Satoshi Taniguchi, Junki Maruyama, Slobodan Paessler, Saori Oka, Atsushi Yamashita, Takasuke Fukuhara, Yoshiharu Matsuura, Hideki Tani. Inhibitors of cannabinoid receptor 1 suppress the cellular entry of Lujo virus. Virology. 2023. 587. 109867-109867
  • Kentaro Nagaoka, Hitoshi Kawasuji, Yusuke Takegoshi, Yushi Murai, Makito Kaneda, Kou Kimoto, Hideki Tani, Hideki Niimi, Yoshitomo Morinaga, Kyo Noguchi, et al. Dominant CT Patterns and Immune Responses during the Early Infection Phases of Different SARS-CoV-2 Variants. Viruses. 2023. 15. 6. 1304-1304
  • Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Yumiko Saga, Hiroshi Yamada, Yoshihiro Yoshida, Yusuke Takegoshi, Makito Kaneda, Yushi Murai, Kou Kimoto, et al. Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5. Microbiology spectrum. 2023. 11. 2. e0513122
ｍore...
MISC (79)：
ｍore...
Education (3)：
  • 1998 - 2001 東京大学大学院 医学系研究科 国際保健学専攻 博士課程
  • 1996 - 1998 東京大学大学院 医学系研究科 国際保健学専攻 修士課程
  • 1992 - 1996 Tokyo University of Science Faculty of Industrial Science and Technology Biological Science and Technology
Professional career (1)：
  • 博士(保健学) (東京大学)
Work history (10)：
  • 2020/07 - 現在 Toyama Institute of Health Department of Virology Director
  • 2016/07 - 2020/06 University of Toyama Graduate School of Medicine and Pharmaceutical Sciences for Research
  • 2011/03 - 2016/06 National Institute of Infectious Diseases
  • 2009/04 - 2011/02 Osaka University Research Institute for Microbial Diseases
  • 2008/04 - 2009/03 Osaka University Research Institute for Microbial Diseases
Show all
Awards (2)：
  • 2013/11 - 日本ウイルス学会 第61回日本ウイルス学会学術集会優秀ポスター賞
  • 2010/11 - 日本ウイルス学会 日本ウイルス学会杉浦奨励賞
Association Membership(s) (7)：
日本公衆衛生学会 ,  日本感染症学会 ,  日本ワクチン学会 ,  北陸公衆衛生学会 ,  SFTS研究会 ,  JAPANESE SOCIETY OF CLINICAL VIROLOGY ,  THE JAPANESE SOCIETY FOR VIROLOGY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM